HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehta, V. B. Articles by Besner, G. E. Search for Related Content PubMed PubMed Citation Articles by Mehta, V. B. Articles by Besner, G. E.

Inhibition of NF-B Activation and Its Target Genes by Heparin-Binding Epidermal Growth Factor-Like Growth Factor ¹

Department of Pediatric Surgery, Children’s Research Institute, and Ohio State University, Columbus, OH 43205

Many cells upon injury mount extensive, compensatory responses that increase cell survival; however, the intracellular signals that regulate these responses are not completely understood. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) has been implicated as a cytoprotective agent. We have previously demonstrated that pretreatment of human intestinal epithelial cells with HB-EGF significantly decreased cytokine-induced activation of inducible NO synthase mRNA expression and NO production and protected the cells from apoptosis and necrosis. However, the mechanisms by which HB-EGF exerts these effects are not known. Here we show that cytokine exposure (IL-1 and IFN-) induced NF-B activation and IL-8 and NO production in DLD-1 cells. Transient expression of a dominant negative form of IB decreased NO production, suggesting that the cytokines stimulated NO production in part through activation of NF-B. HB-EGF dramatically suppressed NF-B activity and IL-8 release and decreased NO production in cells pretreated with HB-EGF. HB-EGF blocked NF-B activation by inhibiting IB kinase activation and IB phosphorylation and degradation, thus interfering with NF-B nuclear translocation, DNA-binding activity, and NF-B-dependent transcriptional activity. The data demonstrate that HB-EGF decreases inflammatory cytokine and NO production by interfering with the NF-B signaling pathway. Inhibition of NF-B may represent one of the mechanisms by which HB-EGF exerts its potent anti-inflammatory and cytoprotective effects.

This article has been cited by other articles:

				V. B. Mehta and G. E. Besner Heparin-Binding Epidermal Growth Factor-Like Growth Factor Inhibits Cytokine-Induced NF-{kappa}B Activation and Nitric Oxide Production via Activation of the Phosphatidylinositol 3-Kinase Pathway J. Immunol., August 1, 2005; 175(3): 1911 - 1918. [Abstract] [Full Text] [PDF]

				Y. Hu, H. Sun, J. Drake, F. Kittrell, M. C. Abba, L. Deng, S. Gaddis, A. Sahin, K. Baggerly, D. Medina, et al. From Mice to Humans: Identification of Commonly Deregulated Genes in Mammary Cancer via Comparative SAGE Studies Cancer Res., November 1, 2004; 64(21): 7748 - 7755. [Abstract] [Full Text] [PDF]